An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss
- 1 April 1992
- journal article
- clinical trial
- Published by Springer Nature in Calcified Tissue International
- Vol. 50 (4) , 381-383
- https://doi.org/10.1007/bf00301638
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatmentThe American Journal of Medicine, 1990
- Effect of salcatonin given intranasally on early postmenopausal bone loss.BMJ, 1989
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.Journal of Clinical Investigation, 1988
- CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSSThe Lancet, 1988
- Sex steroids and bone mass. A study of changes about the time of menopause.Journal of Clinical Investigation, 1987
- ASSESSMENT OF THE BIOLOGICAL EFFECTIVENESS OF NASAL SYNTHETIC SALMON-CALCITONIN (SSCT) BY COMPARISON WITH INTRAMUSCULAR (IM) OR PLACEBO INJECTION IN NORMAL SUBJECTS1987
- Serum Osteocalcin and Total Body Calcium in Normal Pre- and Postmenopausal Women and Postmenopausal Osteoporotic Patients*Journal of Clinical Endocrinology & Metabolism, 1987
- Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical studyCalcified Tissue International, 1986
- Long-term calcitonin therapy in postmenopausal osteoporosisMetabolism, 1984